Image

To combat the lack of comparative trials conducted in regards to antihypertensive medications for children with Chronic Kidney Disease (CKD), Michele Denburg, MD, MSCE and Yong Chen, PhD, collaborated with other researchers to conduct a study using target trial emulation methods and examined two treatment options: RAASi (renin-angiotensin-aldosterone system inhibition) and CCB (calcium channel blockade).

Authors

Michelle R Denburg, Amy J Goodwin Davies, Mitchell G Maltenfort, Mark M Mitsnefes, Joseph T Flynn, Alicia M Neu, Bradley P Dixon, Dorey A Glenn, Caroline A Gluck, Lyndsay A Harshman, Chryso P Katsoufis, Mary B Leonard, Zubin J Modi, Cynthia G Pan, Hiren P Patel, Larry T Patterson, Priya S Verghese, Amy C Wilson, Aneta Jovanovska, Rebecca Levondosky, Mark Levondosky, Kimberley Dickinson, Kaleigh Wieand, Hanieh Razzaghi, Lu Li, Yong Chen, Christoper B Forrest, PRESERVE consortium

Image

In a recent study, Elizabeth D. Lowenthal, MD, MSCE joined fellow researchers to evaluate the effectiveness of near-peer lay counselors in improving adolescent mental health across three different sites in Botswana.

Authors

Merrian J Brooks, Sarah A MacLean, Evan L Eschliman, Ohemaa B Poku, Keneilwe Molebatsi, Charisse Ahmed, Phenyo Morakanyane, Patlo Entaile, Makhetha Monyane-Pheko, Kealeboga Morapedi, Onkemetse Phoi, Ontibile Tshume, Tami D Benton, Mogomotsi Matshaba, Elizabeth D Lowenthal

Image

In a recent study, Roger Y. Kim, MD, MSCE and Katharine A Rendle, PhD, MSW, MPH, along with other researchers, investigated gaps in the risk assessment of pulmonary nodules.

Authors

Roger Y Kim, Aasha Gupta, Lee Ang, Andrea Bilger, Anil Vachani, Katharine A Rendle

Wednesday, June 3, 2026
9:00 am
Have Directed Acyclic Graphs (DAGs) Fulfilled Their Promise in Epidemiology and Health Research?
Wednesday, May 27, 2026
9:00 am
Can an Algorithm Judge a Kidney? Survival Prediction and the Limits of Risk Modeling in Kidney Transplantation
Wednesday, May 13, 2026
9:00 am
How Neighborhoods Shape Overdose Risk: Evidence from Spatial and Quasi-Experimental Studies
Wednesday, May 6, 2026
9:00 am
Evaluating the Effect of Deprescribing Antimuscarinic Overactive Bladder Medications on Cognitive Function and Quality of Life of Individuals with Parkinson Disease using a Pharmacist-led Series of N-of-1 Trials
Ashkan Ertefaie, PhD

Ashkan Ertefaie, PhD

Ashkan Ertefaie is an Associate Professor of Biostatistics at the University of Pennsylvania whose research focuses on developing robust, efficient, and data-adaptive statistical methods with minimal reliance on restrictive modeling assumptions. His work integrates modern machine learning with valid statistical inference and spans causal inference, individualized treatment strategies, instrumental variable methods, high-dimensional data analysis, post-selection inference, and survival analysis. He has served as principal investigator or contact PI on multiple NIH-funded projects, leading methodological advances in areas such as air pollution and cardiovascular disease, just-in-time adaptive interventions for substance use, personalized treatment strategies for Parkinson’s disease, and compliance-adjusted analyses in sequential treatment settings. His research is motivated by important public health and clinical questions and aims to produce practical tools for precision medicine and policy-relevant decision making.

Subscribe to